A new wave of biotech venture capital firms, led by younger investors, is reshaping the industry with fresh strategies and a ...

This move will help shore up the U.S. pharmaceutical supply chain, which currently relies heavily on foreign sources for key raw ingredients. Also in the news: prescription drug legislation, uses of ...

Indianapolis-based pharmaceutical giant Eli Lilly and Co. announced plans Wednesday to add four new manufacturing sites in a roughly $27 billion investment expected to create 3,000 jobs and nearly ...

The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to ...

Lilly’s commitment came a day after tech giant Apple announced a $500 billion commitment over the next four years to its ...

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Thursday as the stock market digests Nvidia earnings and Trump Tariffs Threats on Europe.

Even as President Donald Trump wages a very public fight against diversity, equity and inclusion (DEI) initiatives in the ...

The Indianapolis-based pharmaceutical company announced plans for four new manufacturing sites, but has not decided where ...

The pharmaceutical company expects the expansion will create thousands of jobs.

Eli Lilly plans to invest $27 billion in new U.S. plants amidst threats of drug import tariffs by the Trump administration.

Eli Lilly will spend at least $27 billion dollars to build four manufacturing plants in the U.S. in order to move production back to America.

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas. The ...